Shōichi Kanatomo

448 total citations
31 papers, 309 citations indexed

About

Shōichi Kanatomo is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Shōichi Kanatomo has authored 31 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Shōichi Kanatomo's work include Synthesis and Biological Activity (6 papers), Cancer therapeutics and mechanisms (5 papers) and Chemical Synthesis and Analysis (4 papers). Shōichi Kanatomo is often cited by papers focused on Synthesis and Biological Activity (6 papers), Cancer therapeutics and mechanisms (5 papers) and Chemical Synthesis and Analysis (4 papers). Shōichi Kanatomo collaborates with scholars based in Japan and India. Shōichi Kanatomo's co-authors include Akimori Wada, Tetsu Hase, Katsuhiko Matsui, Junpei Yamamoto, Hiromi Yamamoto, Yoshio Arata, Shigeyuki Yoshifuji, T. HASE, Ken‐ichi Tanaka and Shin‐ichiro Sakai and has published in prestigious journals such as Synthesis, Chemical and Pharmaceutical Bulletin and Journal of Heterocyclic Chemistry.

In The Last Decade

Shōichi Kanatomo

29 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shōichi Kanatomo Japan 9 148 118 54 37 28 31 309
Kenichi Mochida Japan 10 186 1.3× 82 0.7× 13 0.2× 29 0.8× 12 0.4× 33 348
Michael J. Salvatore United States 6 208 1.4× 325 2.8× 18 0.3× 66 1.8× 30 1.1× 9 617
G. A. MORRISON United Kingdom 10 126 0.9× 107 0.9× 15 0.3× 26 0.7× 21 0.8× 46 296
J. H. COATS United States 12 201 1.4× 97 0.8× 9 0.2× 47 1.3× 27 1.0× 22 346
Reiko Abe Japan 11 251 1.7× 245 2.1× 21 0.4× 80 2.2× 26 0.9× 20 534
H. Korth Germany 12 167 1.1× 63 0.5× 8 0.1× 37 1.0× 36 1.3× 38 372
F. G. Holliman United Kingdom 10 145 1.0× 117 1.0× 9 0.2× 33 0.9× 24 0.9× 32 289
Newell O. Sjolander 12 191 1.3× 54 0.5× 40 0.7× 59 1.6× 12 0.4× 16 367
Ikuo Kojima Japan 15 373 2.5× 82 0.7× 20 0.4× 49 1.3× 48 1.7× 46 533
Ryosaku Nomi Japan 12 342 2.3× 105 0.9× 119 2.2× 37 1.0× 33 1.2× 56 539

Countries citing papers authored by Shōichi Kanatomo

Since Specialization
Citations

This map shows the geographic impact of Shōichi Kanatomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shōichi Kanatomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shōichi Kanatomo more than expected).

Fields of papers citing papers by Shōichi Kanatomo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shōichi Kanatomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shōichi Kanatomo. The network helps show where Shōichi Kanatomo may publish in the future.

Co-authorship network of co-authors of Shōichi Kanatomo

This figure shows the co-authorship network connecting the top 25 collaborators of Shōichi Kanatomo. A scholar is included among the top collaborators of Shōichi Kanatomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shōichi Kanatomo. Shōichi Kanatomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanatomo, Shōichi, et al.. (1996). Study on Surfactin, a Cyclic Depsipeptide. II. Synthesis of Surfactin B2 Produced by Bacillus natto KMD 2311.. Chemical and Pharmaceutical Bulletin. 44(1). 5–10. 31 indexed citations
2.
Wada, Akimori, et al.. (1990). Synthesis of 5‐substituted pyrimidines.ortho‐directed lithiation of pyrimidine derivatives. Journal of Heterocyclic Chemistry. 27(6). 1831–1835. 14 indexed citations
3.
Wada, Akimori, Takeshi Nakagawa, & Shōichi Kanatomo. (1989). A Convenient Synthesis of 7-Aryl-2,4-dimethoxy-5-oxo-5H-pyrano[4,3-d]pyrimidines. Synthesis. 1989(4). 316–317. 1 indexed citations
4.
Kanatomo, Shōichi, et al.. (1989). Sparsomycin analogs. VI. Synthesis and antitumor activity of octylsparsomycin analogs.. Chemical and Pharmaceutical Bulletin. 37(3). 688–691. 1 indexed citations
5.
Kanatomo, Shōichi, et al.. (1988). Sparsomycin analogs. IV. Synthesis and antitumor activity of pyrimidine-5-carboxamides and(E)-.BETA.-(pyrimidin-5-yl)-acrylamides.. Chemical and Pharmaceutical Bulletin. 36(6). 2042–2049. 5 indexed citations
7.
Wada, Akimori, Hiromi Yamamoto, & Shōichi Kanatomo. (1988). Anionic Cycloaddition of Methyl 2,4-Dimethoxy-6-methyl-5-pyrimidinecarboxylate with Acetylenes and Olefins. Heterocycles. 27(6). 1345–1345. 9 indexed citations
8.
Kanatomo, Shōichi, et al.. (1988). Sparsomycin analogs. V. Synthesis and antitumor activity of (E)-.BETA.-(pyrimidin-5-yl)acrylamides.. Chemical and Pharmaceutical Bulletin. 36(11). 4421–4425. 1 indexed citations
9.
Kanatomo, Shōichi, et al.. (1984). Sparsomycin analogs. III. Synthesis and biological activities of (E)-.BETA.-(6-methyluracil-5-yl)acrylic acid derivatives.. Chemical and Pharmaceutical Bulletin. 32(11). 4625–4631. 2 indexed citations
10.
Kanatomo, Shōichi, et al.. (1981). Sparsomycin analogs. I. Synthesis of 5-carboxy-6-methyluracil.. Chemical and Pharmaceutical Bulletin. 29(1). 229–232.
11.
Hase, Tetsu, et al.. (1978). Studies on acylase activity and micro-organisms. XXVI. Purification and properties of D-acylase (N-acyl-D-amino-acid amidohydrolase) from AAA 6029 (Pseudomonas sp.).. Chemical and Pharmaceutical Bulletin. 26(9). 2698–2704. 16 indexed citations
12.
Nakabayashi, Toshikatsu, et al.. (1978). Parification and properties of acylase from Ehrlich ascites carcinoma cells.. Chemical and Pharmaceutical Bulletin. 26(12). 3785–3791. 1 indexed citations
13.
Matsui, Katsuhiko, et al.. (1974). Antitumor Activity of Bacillus natto. V. Isolation and Characterization of Surfactin in the Culture Medium of Bacillus natto KMD 2311. Chemical and Pharmaceutical Bulletin. 22(4). 938–944. 116 indexed citations
14.
Sagai, Hitoshi, et al.. (1971). Antitumor Activity of Bacillus natto. II. Formation of Cytolytic Substances on Ehrlich Ascites Carcinoma in Bacillus natto KMD 1126. Chemical and Pharmaceutical Bulletin. 19(12). 2572–2578. 1 indexed citations
15.
Tomoeda, Munemitsu, Masayuki Ishizaki, Harumi Kobayashi, et al.. (1964). The Polyphosphoric Acid-Catalyzed Ring Opening of 4, 5-Epoxy-3-oxo Steroids : The Synthesis of 4-Alkylthio-4-en-3-oxo Steroids and their Analogs. Chemical and Pharmaceutical Bulletin. 12(3). 383–385. 4 indexed citations
16.
Kanatomo, Shōichi & Shin‐ichiro Sakai. (1961). Studies on Bitter Principles of <i>Isodon trichocarpus</i>. IV. YAKUGAKU ZASSHI. 81(12). 1807–1808. 3 indexed citations
17.
Kanatomo, Shōichi. (1958). Alkaline Decomposition of Enmein.. Chemical and Pharmaceutical Bulletin. 6(6). 680–682. 4 indexed citations
18.
Kosuge, Takuo, et al.. (1958). Communications to the Editor. YAKUGAKU ZASSHI. 78(8). 947–948. 2 indexed citations
19.
Yamamoto, Yuzuru, et al.. (1956). Studies on Ultraviolet Spectra of Hydroxyanthraquinones. YAKUGAKU ZASSHI. 76(2). 217–220. 3 indexed citations
20.
Yamamoto, Yuzuru, et al.. (1956). Studies on the Metabolic Products of <i>Penicillium islandicum</i> SOPP. IV. YAKUGAKU ZASSHI. 76(6). 670–673. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026